Back to blog
    Testing and Purity

    Peptide Stability and Storage: Preventing Degradation in Research Settings

    3 April 202610 min readBy the Peptx research team

    Even high-purity peptides can degrade rapidly under improper storage conditions. This guide covers the major degradation pathways, optimal storage conditions, and practical considerations for maximising peptide shelf life in research environments.

    A peptide that tests at 99% purity at the point of manufacture can degrade to below usable levels within weeks if stored improperly. Understanding the chemical and physical factors that drive peptide degradation is essential for any laboratory working with research-grade compounds.

    Major Degradation Pathways

    1. Oxidation

    Methionine, cysteine, tryptophan, and histidine residues are susceptible to oxidation. Methionine sulphoxide formation is the most common oxidative degradation product. Exposure to atmospheric oxygen, light, and trace metal ions (particularly Fe2+ and Cu2+) accelerates this process [1].

    Practical impact: oxidised peptides may retain partial biological activity but will show altered HPLC profiles and reduced receptor binding affinity. For quantitative assays, even minor oxidation can introduce significant experimental variability.

    2. Deamidation

    Asparagine and glutamine residues undergo deamidation, converting to aspartic acid and glutamic acid respectively, which changes the charge and conformation of the peptide over time [2]. In a model hexapeptide study, the deamidation rate depended markedly on pH, temperature and buffer composition, with the reaction running through a cyclic imide intermediate from pH 5 to 12 [3].

    Deamidation introduces a charge change that alters peptide behaviour in binding assays and can be detected as a mass shift of +1 Da on mass spectrometry.

    3. Hydrolysis

    Peptide bonds can be cleaved by hydrolysis, particularly at Asp-Pro and Asp-Gly sequences. This is accelerated under acidic conditions and elevated temperatures. Hydrolysis produces truncated fragments that may or may not retain biological activity.

    4. Aggregation

    Some peptides, particularly those with hydrophobic regions, can self-associate into aggregates or fibrils. This is often irreversible and renders the peptide biologically inactive. Aggregation is promoted by high concentrations, freeze-thaw cycling, and agitation [4].

    5. Adsorption

    Many peptides can adsorb to container surfaces, including standard polypropylene tubes and glass vials, and recovery varies between peptides and container types [5]. This effectively reduces the concentration of peptide in solution and can introduce apparent potency losses that are not due to chemical degradation.

    Optimal Storage Conditions

    Lyophilised (Freeze-Dried) Peptides

    • Store at -20C or below. -80C is preferred for long-term storage (more than 6 months)
    • Protect from light using amber vials or foil wrapping
    • Maintain a desiccant in the storage container to prevent moisture absorption
    • Avoid repeated temperature cycling: allow vials to equilibrate to room temperature before opening
    • Under these conditions, most peptides remain stable for 12 to 24 months

    Reconstituted Peptides

    • Use sterile, bacteriostatic water or appropriate buffer at the correct pH for the specific peptide
    • Store reconstituted peptides at 2 to 8C for short-term use (up to 4 weeks)
    • For longer storage, aliquot into single-use volumes and store at -20C to avoid freeze-thaw cycles
    • Choose tubes suited to the specific peptide to minimise adsorption; in one comparison, adding a carrier protein (BSA) improved peptide recovery while siliconising tubes reduced it [5]
    • Record the reconstitution date and discard according to the stability data for the specific peptide

    Reconstitution Methodology in Research Settings

    Standard laboratory reconstitution methodology involves allowing the lyophilised vial to reach room temperature before opening (approximately 15 to 20 minutes), then adding solvent slowly down the side of the vial rather than directly onto the lyophilised cake. The vial is then gently swirled or rotated rather than vortexed, since vortexing can promote aggregation and foaming. The peptide is allowed to dissolve completely, which may take 10 to 15 minutes for some sequences, and dissolution is verified visually: the resulting solution should be clear and free of particulate matter.

    Stability Testing for Received Material

    Laboratories establishing a new supplier relationship can apply the following stability verification approach:

    1. Test purity by HPLC upon receipt (baseline measurement)
    2. Store a reference aliquot under standard laboratory conditions
    3. Retest at 1 month, 3 months, and 6 months
    4. Compare chromatographic profiles for new peaks indicating degradation
    5. If degradation exceeds 2% per month, investigate storage conditions or switch suppliers

    Common Mistakes

    • Storing at room temperature: Even lyophilised peptides degrade at 20 to 25C, particularly those containing Met, Cys, or Asn residues
    • Repeated freeze-thaw cycles: Each cycle promotes aggregation. Aliquot into single-use volumes immediately after reconstitution
    • Using the wrong solvent: Some peptides require DMSO or acidified water for proper dissolution. Using water alone may result in incomplete dissolution or immediate aggregation
    • Ignoring container compatibility: Standard plastic and glass containers can adsorb a large share of some peptides from dilute solutions; one study found that 90% or more of three cationic peptides could be lost to container walls [6]

    References

    1. [1] Li S, et al. "Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization." Biotechnol Bioeng. 1995;48(5):490-500. PubMed 18623513
    2. [2] Robinson NE, Robinson AB. "Deamidation of human proteins." Proc Natl Acad Sci USA. 2001;98(22):12409-12413. PubMed 11606750
    3. [3] Patel K, Borchardt RT. "Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide." Pharm Res. 1990;7(7):703-711. PubMed 2395797
    4. [4] Wang W. "Instability, stabilization, and formulation of liquid protein pharmaceuticals." Int J Pharm. 1999;185(2):129-188. PubMed 10460913
    5. [5] Goebel-Stengel M, et al. "The importance of using the optimal plasticware and glassware in studies involving peptides." Anal Biochem. 2011;414(1):38-46. PubMed 21315060
    6. [6] Kristensen K, et al. "Adsorption of cationic peptides to solid surfaces of glass and plastic." PLoS One. 2015;10(5):e0122419. PubMed 25932639

    Browse the Peptx catalogue

    Independently tested compounds, typically 99%+ purity (HPLC), factory-direct pricing. UK stock dispatches within 24 hours.

    Sold strictly for laboratory research. Not for human consumption.